Does PALIPERIDONE Cause Product packaging quantity issue? 9 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Product packaging quantity issue have been filed in association with PALIPERIDONE (paliperidone). This represents 0.0% of all adverse event reports for PALIPERIDONE.
9
Reports of Product packaging quantity issue with PALIPERIDONE
0.0%
of all PALIPERIDONE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product packaging quantity issue From PALIPERIDONE?
Of the 9 reports.
Is Product packaging quantity issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALIPERIDONE. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does PALIPERIDONE Cause?
Injury (4,348)
Gynaecomastia (4,155)
Off label use (4,041)
Drug ineffective (2,812)
Weight increased (2,136)
Hospitalisation (2,066)
Abnormal weight gain (1,816)
Hyperprolactinaemia (1,427)
Schizophrenia (1,361)
Product dose omission issue (1,304)
What Other Drugs Cause Product packaging quantity issue?
LEUPROLIDE (523)
ALBUTEROL (431)
BUDESONIDE\FORMOTEROL (301)
FENTANYL (286)
BUPRENORPHINE (225)
CYCLOSPORINE (206)
ESTRADIOL (201)
BIMATOPROST (177)
RIVAROXABAN (174)
EXENATIDE (154)
Which PALIPERIDONE Alternatives Have Lower Product packaging quantity issue Risk?
PALIPERIDONE vs PALIVIZUMAB
PALIPERIDONE vs PALONOSETRON
PALIPERIDONE vs PAMIDRONATE
PALIPERIDONE vs PAMIDRONIC ACID
PALIPERIDONE vs PANCRELIPASE